The inclusion of “health heart diagnostics” (HHD) in the CBC + PS + ESR test description highlights the test’s importance in the treatment of cardiovascular health. These tests are primarily intended to evaluate blood health and inflammation, but the data they yield can be extremely important for cardiovascular diagnosis. For example, ESR-detected systemic inflammation is recognized to be a risk factor for cardiovascular disorders, including atherosclerosis. Additionally, variations in blood cell numbers and properties can affect blood clotting and viscosity, two essential elements in the treatment of cardiac disease.
Thus, thorough hematologic profiling is crucial for both diagnosing and tracking blood-related health problems. It also plays a vital role in cardiac diagnostics, providing vital information about the relationship between cardiovascular and hematological disorders.